Total Payments
$1,503
2024 Payments
$20.37
Companies
25
Transactions
104
Medicare Patients
5,680
Medicare Billing
$317,273
Payment Breakdown by Category
Food & Beverage$1,503 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,503 | 104 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $303.45 | 22 | $0 (2022) |
| ABBVIE INC. | $282.42 | 21 | $0 (2022) |
| Lilly USA, LLC | $119.23 | 10 | $0 (2021) |
| GlaxoSmithKline, LLC. | $110.57 | 7 | $0 (2022) |
| Astellas Pharma US Inc | $94.12 | 6 | $0 (2021) |
| Amarin Pharma Inc. | $82.30 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $68.46 | 5 | $0 (2022) |
| Amgen Inc. | $48.06 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $44.43 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $41.22 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.37 | 1 | Biogen, Inc. ($20.37) |
| 2022 | $530.22 | 34 | ABBVIE INC. ($140.16) |
| 2021 | $952.08 | 69 | Novo Nordisk Inc ($183.19) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Neurology | ||||||
| 06/29/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: UROLOGY | ||||||
| 05/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Gastroenterology | ||||||
| 04/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 04/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Diabetes | ||||||
| 04/12/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Inflammation | ||||||
| 04/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 04/11/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/11/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: IMMUNOLOGY | ||||||
| 03/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardio-renal | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 03/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Diabetes | ||||||
| 03/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,582 | 3,067 | $347,115 | $143,291 |
| 2022 | 21 | 1,708 | 2,097 | $219,325 | $97,801 |
| 2021 | 22 | 1,212 | 1,843 | $136,967 | $68,751 |
| 2020 | 6 | 178 | 184 | $13,154 | $7,432 |
Total Patients
5,680
Total Services
7,191
Medicare Billing
$317,273
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 452 | $70,060 | $32,854 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 353 | 353 | $84,720 | $31,896 | 37.6% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 208 | 217 | $43,400 | $20,372 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 346 | 387 | $40,635 | $19,627 | 48.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 289 | 305 | $30,500 | $15,335 | 50.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 243 | 243 | $38,880 | $14,164 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $3,250 | $1,546 | 47.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 103 | 124 | $4,092 | $940.14 | 23.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 51 | 53 | $5,300 | $924.97 | 17.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 51 | 51 | $1,632 | $826.20 | 50.6% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2023 | 25 | 25 | $1,203 | $560.13 | 46.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 217 | 249 | $4,980 | $547.80 | 11.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 30 | 30 | $2,280 | $478.26 | 21.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,177 | $432.92 | 36.8% |
| 90471 | Administration of vaccine | Office | 2023 | 35 | 35 | $1,820 | $415.51 | 22.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 20 | 21 | $1,596 | $401.25 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $792.00 | $365.20 | 46.1% |
| 71101 | X-ray of ribs on side of body, minimum of 3 views | Office | 2023 | 16 | 16 | $1,728 | $334.92 | 19.4% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 12 | 12 | $924.00 | $281.05 | 30.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 33 | 35 | $1,435 | $266.35 | 18.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 33 | 33 | $990.00 | $220.55 | 22.3% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 11 | 11 | $836.00 | $215.85 | 25.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 12 | 12 | $956.07 | $129.81 | 13.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $720.00 | $111.43 | 15.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 72 | $1,948 | $23.87 | 1.2% |
About Holly Poplin, APRN
Holly Poplin, APRN is a Nurse Practitioner healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2020. The National Provider Identifier (NPI) number assigned to this provider is 1134736309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Holly Poplin, APRN has received a total of $1,503 in payments from pharmaceutical and medical device companies, with $20.37 received in 2024. These payments were reported across 104 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,503).
As a Medicare-enrolled provider, Poplin has provided services to 5,680 Medicare beneficiaries, totaling 7,191 services with total Medicare billing of $317,273. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Primary Care
- Location Little River, SC
- Active Since 09/30/2020
- Last Updated 11/15/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1134736309
Products in Payments
- VRAYLAR (Drug) $157.08
- RYBELSUS (Drug) $153.17
- TRELEGY ELLIPTA (Drug) $110.57
- MYRBETRIQ (Drug) $94.12
- Ozempic (Drug) $87.17
- Vascepa (Drug) $82.30
- FARXIGA (Drug) $68.46
- JARDIANCE (Drug) $46.35
- XARELTO (Drug) $44.43
- TRULICITY (Drug) $42.73
- INJECTAFER (Drug) $37.20
- ENTRESTO (Drug) $36.72
- Otezla (Drug) $36.40
- UBRELVY (Drug) $35.59
- Rybelsus (Drug) $33.09
- Kerendia (Drug) $32.32
- EMGALITY (Drug) $30.15
- Wegovy (Drug) $30.02
- XIFAXAN (Drug) $28.35
- SYNTHROID (Drug) $27.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Little River
Megan Lentz, Fnp, FNP
Nurse Practitioner — Payments: $1,154
Nurse Practitioner $1,154
Antonela Ratiu, Aprn, APRN
Nurse Practitioner — Payments: $858.66
Nurse Practitioner $858.66
Rachel Hester, Fnp-C, FNP-C
Nurse Practitioner — Payments: $242.70
Nurse Practitioner $242.70
Wendy Mote, Aprn, APRN
Nurse Practitioner — Payments: $19.50
Nurse Practitioner $19.50
Andrea Simmons Nance, Fnp, FNP
Nurse Practitioner
Nurse Practitioner
Laura Baxley, Fnp-C, FNP-C
Nurse Practitioner
Nurse Practitioner